The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Anti-Obesity Activity of the Marine Carotenoid Fucoxanthin
Open accessAbstract
Nowadays the global tendency towards physical activity reduction and an augmented dietary intake of fats, sugars and calories is leading to a growing propagation of overweight, obesity and lifestyle-related diseases, such diabetes, hypertension, dyslipidemia and metabolic syndrome. In particular, obesity, characterized as a state of low-level inflammation, is a powerful determinant both in the development of insulin resistance and in the progression to type 2 diabetes. A few molecular targets offer hope for anti-obesity therapeutics. One of the keys to success could be the induction of uncoupling protein 1 (UCP1) in abdominal white adipose tissue (WAT) and the regulation of cytokine secretions from both abdominal adipose cells and macrophage cells infiltrated into adipose tissue. Anti-obesity effects of fucoxanthin, a characteristic carotenoid, exactly belonging to xanthophylls, have been reported. Nutrigenomic studies reveal that fucoxanthin induces UCP1 in abdominal WAT mitochondria, leading to the oxidation of fatty acids and heat production in WAT. Fucoxanthin improves insulin resistance and decreases blood glucose levels through the regulation of cytokine secretions from WAT. The key structure of anti-obesity effect is suggested to be the carotenoid end of the polyene chromophore, which contains an allenic bond and two hydroxyl groups. Fucoxanthin, which can be isolated from edible brown seaweeds, recently displayed its many physiological functions and biological properties. We reviewed recent studies and this article aims to explain essential background of fucoxanthin, focusing on its promising potential anti-obesity effects. In this respect, fucoxanthin can be developed into promising marine drugs and nutritional products, in order to become a helpful functional food.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robbins and Cotran Pathologic Basis of Disease
Hoda, S. A., & Hoda, R. S. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa163 · Cited by 3,365
SREBP transcription factors: master regulators of lipid homeostasis
Eberlé, D., Hegarty, B., Bossard, P., Ferré, P., & Foufelle, F. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.018 · Cited by 1,529
Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., & Garg, R. (2005) · Circulation · doi:10.1161/01.cir.0000158483.13093.9d · Cited by 1,263
A review of the interaction among dietary antioxidants and reactive oxygen species
Seifried, H. E., Anderson, D. E., Fisher, E. I., & Milner, J. A. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.10.007 · Cited by 894
Adipocyte Differentiation and Gene Expression
Ntambi, J. M., & Young-Cheul, K. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.12.3122s · Cited by 778
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c
Ferré, P., & Foufelle, F. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01275.x · Cited by 704
Maeda, H., Hosokawa, M., Sashima, T., Funayama, K., & Miyashita, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.002 · Cited by 639
The gut microbiota, obesity and insulin resistance
Shen, J., Obin, M. S., & Zhao, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.001 · Cited by 599
Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery
Tong, L. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5121-4 · Cited by 446
A Potential Commercial Source of Fucoxanthin Extracted from the Microalga Phaeodactylum tricornutum
Kim, S. M., Jung, Y.-J., Kwon, O.-N., Cha, K. H., Um, B.-H., Chung, D., & Pan, C.-H. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9602-2 · Cited by 417
Cited by
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2017) · Natural Product Reports · doi:10.1039/c6np00124f · Cited by 465
Microalgal Carotenoids: A Review of Production, Current Markets, Regulations, and Future Direction
Novoveská, L., Ross, M. E., Stanley, M. S., Pradelles, R., Wasiolek, V., & Sassi, J.-F. (2019) · Marine Drugs · doi:10.3390/md17110640 · Cited by 462
Omega-3 Polyunsaturated Fatty Acids: Benefits and Endpoints in Sport
Gammone, M. A., Riccioni, G., Parrinello, G., & D’Orazio, N. (2018) · Nutrients · doi:10.3390/nu11010046 · Cited by 326
Self-citationInnovative Alternative Technologies to Extract Carotenoids from Microalgae and Seaweeds
Poojary, M., Barba, F., Aliakbarian, B., Donsì, F., Pataro, G., Dias, D., & Juliano, P. (2016) · Marine Drugs · doi:10.3390/md14110214 · Cited by 313
Seaweed nutraceuticals and their therapeutic role in disease prevention
Ganesan, A. R., Tiwari, U., & Rajauria, G. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.08.001 · Cited by 288
Marine Carotenoids against Oxidative Stress: Effects on Human Health
Gammone, M., Riccioni, G., & D'Orazio, N. (2015) · Marine Drugs · doi:10.3390/md13106226 · Cited by 270
Self-citationCarotenoids from Marine Microalgae: A Valuable Natural Source for the Prevention of Chronic Diseases
Raposo, M., De Morais, A., & De Morais, R. (2015) · Marine Drugs · doi:10.3390/md13085128 · Cited by 228
Microalgae as Functional Ingredients in Savory Food Products: Application to Wheat Crackers
Batista, A. P., Niccolai, A., Bursic, I., Sousa, I., Raymundo, A., Rodolfi, L., Biondi, N., & Tredici, M. R. (2019) · Foods · doi:10.3390/foods8120611 · Cited by 203
Applying Seaweed Compounds in Cosmetics, Cosmeceuticals and Nutricosmetics
López-Hortas, L., Flórez-Fernández, N., Torres, M. D., Ferreira-Anta, T., Casas, M. P., Balboa, E. M., Falqué, E., & Domínguez, H. (2021) · Marine Drugs · doi:10.3390/md19100552 · Cited by 168
Lin, J., Huang, L., Yu, J., Xiang, S., Wang, J., Zhang, J., Yan, X., Cui, W., He, S., & Wang, Q. (2016) · Marine Drugs · doi:10.3390/md14040067 · Cited by 142
Le Goff, M., Le Ferrec, E., Mayer, C., Mimouni, V., Lagadic-Gossmann, D., Schoefs, B., & Ulmann, L. (2019) · Biochimie · doi:10.1016/j.biochi.2019.09.012 · Cited by 123
Overview on the Antihypertensive and Anti-Obesity Effects of Secondary Metabolites from Seaweeds
Seca, A. M. L., & Pinto, D. C. G. A. (2018) · Marine Drugs · doi:10.3390/md16070237 · Cited by 123
Grasa-López, A., Miliar-García, Á., Quevedo-Corona, L., Paniagua-Castro, N., Escalona-Cardoso, G., Reyes-Maldonado, E., & Jaramillo-Flores, M.-E. (2016) · Marine Drugs · doi:10.3390/md14080148 · Cited by 111
Shih, P.-H., Shiue, S.-J., Chen, C.-N., Cheng, S.-W., Lin, H.-Y., Wu, L.-W., & Wu, M.-S. (2021) · Marine Drugs · doi:10.3390/md19030148 · Cited by 86
Heffernan, N., Smyth, T. J., FitzGerald, R. J., Vila-Soler, A., Mendiola, J., Ibáñez, E., & Brunton, N. P. (2016) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2016.06.004 · Cited by 76
The Potential of Algae in the Nutricosmetic Sector
Dini, I. (2023) · Molecules · doi:10.3390/molecules28104032 · Cited by 41
Metadata
- Authors
- Gammone, M., & D'Orazio, N.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2015-04-13
- Volume
- 13
- Issue
- 4
- Pages
- 2196-2214
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W1970187819
- Cited by
- 321
- References
- 67
- FWCI
- 34.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.